Table 3.
Indicators | Group | Time points | Z/P b | Ft/Pt | Fg/Pg | Fi/Pi | △ | ||
---|---|---|---|---|---|---|---|---|---|
Pre | Week 6 | Week 12 | |||||||
FPG | CG | 7.55 ± 2.09 | 7.74 ± 1.85 | 7.70 ± 1.75 | 0.471/0.598 | 1.004/0.322 | 2.338/0.103 | 0.30 (-0.40,1.03) | |
IG | 8.32 ± 2.67 | 7.99 ± 2.39 | 7.60 ± 1.95 | -0.40 (-1.65, -0.80) | |||||
Z | -2.133 | ||||||||
Pa | 0.033 | ||||||||
GSP | CG | 3.22 ± 0.35 | 2.94 ± 0.29† | 2.81 ± 0.28†† | 86.420/<0.01 | 2.191/0.147 | 4.672/0.016 | -0.35 (-0.67, -0.18) | |
IG | 3.43 ± 0.56 | 3.03 ± 0.38† | 2.83 ± 0.37†† | -0.47 (-0.92, -0.25) | |||||
F | 4.220 | 1.662 | 0.056 | -1.840 | |||||
P | 0.047 | 0.210 | 0.815 | 0.066 | |||||
HbA1c | CG | 7.0 (6.4, 7.7) | / | 6.9 (6.2, 7.8) | -1.031/0.303 | -0.2 (-0.2, 0.3) | |||
IG | 7.0 (6.4, 8.6) | / | 6.9 (6.5, 8.7) | -0.598/0.550 | 0.0 (-0.4, 0.3) | ||||
Z | -0.515 | -0.647 | -0.394 | ||||||
P a | 0.606 | 0.517 | 0.694 |
Mann–Whitney U test;
Wilcoxon signed rank test; Ft/Pt, Fg/Pg , and Fi/Pi : two-way repeated measures ANOVA, time effect, group effect and group. *time interaction;
†: P<0.05 vs. Pre; ††: P<0.05 vs. Week 6; CG, control group; IG, intervention group; SD, standard deviation; △, value at week 12 minus value at pre.